Innophos Holdings Inc $ 31.99 0 (0%)
Volume:
0
Avg Vol (1m):
0
Market Cap $:
629.91 Mil
Enterprise Value $:
995.09 Mil
P/E (TTM):
29.90
P/B:
1.86
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.08 | ||
| Equity-to-Asset | 0.39 | ||
| Debt-to-Equity | 1.17 | ||
| Debt-to-EBITDA | 3.98 | ||
| Interest Coverage | 3.68 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 2.69 | ||
| Beneish M-Score | -2.67 | ||
Profitability Rank | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 7.4 | ||
| Net Margin % | 2.82 | ||
| ROE % | 6.26 | ||
| ROA % | 2.52 | ||
| ROC (Joel Greenblatt) % | 12.48 | ||
| 3-Year Revenue Growth Rate | 1.5 | ||
| 3-Year EBITDA Growth Rate | 6.8 | ||
| 3-Year EPS without NRI Growth Rate | 12.2 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 29.9 | ||
| PE Ratio without NRI | 29.9 | ||
| Price-to-Owner-Earnings | 477.46 | ||
| PB Ratio | 1.86 | ||
| PS Ratio | 0.83 | ||
| Price-to-Free-Cash-Flow | 22.25 | ||
| Price-to-Operating-Cash-Flow | 10.03 | ||
| EV-to-EBIT | 17.7 | ||
| EV-to-EBITDA | 9.99 | ||
| EV-to-Revenue | 1.31 | ||
| Shiller PE Ratio | 13.43 | ||
| Current Ratio | 2.94 | ||
| Quick Ratio | 1.48 | ||
| Days Inventory | 101.3 | ||
| Days Sales Outstanding | 51.11 | ||
| Days Payable | 33.86 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 4.5 | ||
| Dividend Payout Ratio | 1.78 | ||
| Forward Dividend Yield % | 6 | ||
| 5-Year Yield-on-Cost % | 5.72 | ||
| 3-Year Average Share Buyback Ratio | -0.6 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 6.22 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 0.79 | ||
| Price-to-Median-PS-Value | 0.66 | ||
| Price-to-Graham-Number | 2.88 | ||
| Earnings Yield (Greenblatt) % | 5.65 | ||
| Forward Rate of Return (Yacktman) % | 5.84 |